9,531 Shares in Centene Corporation $CNC Purchased by Fielder Capital Group LLC

Fielder Capital Group LLC bought a new stake in Centene Corporation (NYSE:CNC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 9,531 shares of the company’s stock, valued at approximately $392,000.

Several other hedge funds also recently made changes to their positions in CNC. Baird Financial Group Inc. acquired a new position in Centene during the first quarter worth $236,000. Sivia Capital Partners LLC increased its stake in Centene by 80.0% in the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock valued at $527,000 after buying an additional 4,315 shares during the last quarter. CW Advisors LLC lifted its position in Centene by 20.3% during the 2nd quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock worth $264,000 after buying an additional 820 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of Centene by 6.1% during the 2nd quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after buying an additional 2,582 shares during the last quarter. Finally, Treasurer of the State of North Carolina increased its position in shares of Centene by 0.4% in the second quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock valued at $12,590,000 after acquiring an additional 967 shares during the last quarter. 93.63% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CNC has been the subject of several recent research reports. Jefferies Financial Group increased their price target on Centene from $39.00 to $48.00 and gave the company a “hold” rating in a research report on Wednesday, April 29th. Zacks Research raised Centene from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 6th. Wells Fargo & Company increased their price objective on Centene from $44.00 to $56.00 and gave the company an “equal weight” rating in a report on Friday, May 1st. JPMorgan Chase & Co. raised their target price on shares of Centene from $41.00 to $52.00 and gave the company a “neutral” rating in a research note on Tuesday, May 5th. Finally, Truist Financial upped their price target on shares of Centene from $58.00 to $71.00 and gave the stock a “buy” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $58.94.

Centene Stock Down 3.4%

Centene stock opened at $59.90 on Wednesday. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $62.10. The stock has a market cap of $29.58 billion, a P/E ratio of -4.56, a P/E/G ratio of 0.48 and a beta of 1.09. The company’s 50-day moving average price is $45.97 and its two-hundred day moving average price is $42.66. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.76.

Centene (NYSE:CNC) last posted its earnings results on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, beating the consensus estimate of $2.23 by $1.14. The company had revenue of $49.94 billion for the quarter, compared to the consensus estimate of $47.53 billion. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.90 earnings per share. As a group, analysts expect that Centene Corporation will post 3.45 EPS for the current year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.